Funded Tech Companies
Amyl Therapeutics
Amyl Therapeutics, based in Liège, has financial backing from Merieux Developpement, Noshaq and private investors.
Company Overview
Company Name
Amyl Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
LegiaPark, Boulevard Patience et Beaujonc 3, box 12
Liège, 4000
Belgium
Liège, 4000
Belgium
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Amyl Therapeutics is a preclinical-stage biotechnology company pioneering Pan-Amyloid Immunotherapy (PAI), a universal approach to treating amyloid-mediated neurodegenerative diseases. Amyloid aggregates are involved in more than 30 disorders, including high-burden neurodegenerative diseases such as Alzheimer's and Parkinson's, as well as rare conditions like systemic amyloidosis.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/1/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pierre Vandepapelière
Chief Financial Officer
Christophe Mathieu
Chief Scientific Officer
Damien Toulorge
VP - R & D
Julie Goemaere
Company Investors
- Merieux Developpement
- Noshaq
Browse more funded tech companies:
Amygdala Neurosciences | Amylin Pharmaceuticals
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs